Michael Barbella, Managing Editor03.25.24
DiagnaMed Holdings Corp. has initiated the pilot launch of CERVAI, a consumer brain health and wellness AI solution that measures cerebral health issues by estimating brain age and providing an overall brain health score.
“After over two years in development, CERVAI, a consumer brain health and wellness solution that estimates brain age and provides a brain health score, is available to clinics seeking to provide a service that helps bridge the gaps in physical and cognitive health while enhancing client engagement and design personalized interventions in improving overall brain health," DiagnaMed Chairman/CEO Fabio Chianelli said.
Based on research and development at Drexel University and the University of Miami, CERVAI combines a Brain Age Estimation and Brain Health Assessment tool. CERVAI can assess if a brain is aging more quickly or more slowly than is typical for healthy individuals. Brain age is estimated by collecting neural activity data of the brain with a low-cost and easy-to-use electroencephalogram (EEG) headset and calculating the data with a proprietary machine-learning model. In addition, CERVAI can assess whether a person has a healthy brain or is in the early stage of cognitive decline. Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability and performance functions. Individuals can seek out personalized diagnostics and interventions, such as medication or lifestyle changes, that may help to decrease the development or progression of cognitive decline.
The CERVAI Brain Health pilot program is open to a select 25 U.S. and Canadian consumer wellness clinics. Ideal clinics for the pilot program must focus on health and wellness, sports and physical therapy, mental health, chiropractic care, or clinical research for neurological and cognitive disorders.
DiagnaMed Holdings Corp. is a digital health artificial intelligence company focused on commercializing CERVAI. The company is based in Toronto, Canada.
“After over two years in development, CERVAI, a consumer brain health and wellness solution that estimates brain age and provides a brain health score, is available to clinics seeking to provide a service that helps bridge the gaps in physical and cognitive health while enhancing client engagement and design personalized interventions in improving overall brain health," DiagnaMed Chairman/CEO Fabio Chianelli said.
Based on research and development at Drexel University and the University of Miami, CERVAI combines a Brain Age Estimation and Brain Health Assessment tool. CERVAI can assess if a brain is aging more quickly or more slowly than is typical for healthy individuals. Brain age is estimated by collecting neural activity data of the brain with a low-cost and easy-to-use electroencephalogram (EEG) headset and calculating the data with a proprietary machine-learning model. In addition, CERVAI can assess whether a person has a healthy brain or is in the early stage of cognitive decline. Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability and performance functions. Individuals can seek out personalized diagnostics and interventions, such as medication or lifestyle changes, that may help to decrease the development or progression of cognitive decline.
The CERVAI Brain Health pilot program is open to a select 25 U.S. and Canadian consumer wellness clinics. Ideal clinics for the pilot program must focus on health and wellness, sports and physical therapy, mental health, chiropractic care, or clinical research for neurological and cognitive disorders.
DiagnaMed Holdings Corp. is a digital health artificial intelligence company focused on commercializing CERVAI. The company is based in Toronto, Canada.